๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cisplatin, doxorubicin, cyclophosphamide, and etoposide combination chemotherapy for small-cell lung cancer

โœ Scribed by Joseph Aisner; Margaret Y. Whitacre; Daniel R. Budman; Kathy Propert; Gary Strauss; David A. Echo; Michael Perry

Publisher
Springer
Year
1992
Tongue
English
Weight
442 KB
Volume
29
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Combination chemotherapy with cisplatin
Combination chemotherapy with cisplatin and etoposide associated with radiotherapy in the treatment of small-cell lung cancer
โœ F. Figoli; A. Veronesi; M. G. Trovo; D. Errante; M. Della Valentina; V. Zagonel; ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› Springer ๐ŸŒ English โš– 447 KB

A total of 52 consecutive, previously untreated patients with small-cell lung cancer (SCLC) were scheduled to receive six cycles of a combination of etoposide (75 mg/m2 per day) and cisplatin (20 mg/m2 per day), each cycle given over 5 consecutive days. In all, 28 patients had extensive disease (ED)